Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics - Takeaways - MDSpire

Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics

  • By

  • Zheng Zhang

  • Lijun He

  • Bin Chen

  • Huanle Zhang

  • July 15, 2026

Share

  • 1

    Clear cell renal cell carcinoma (ccRCC) is linked to VHL loss, HIF signaling, angiogenesis, and immune regulation.

  • 2

    Current biomarkers like PD-L1 and TMB are insufficient for predicting treatment outcomes in ccRCC.

  • 3

    High CD8+ T-cell infiltration in ccRCC may correlate with poorer survival, indicating immune abundance does not equal effectiveness.

  • 4

    An immune ecology framework emphasizes relationships among tumor cells, immune populations, and the microenvironment.

  • 5

    Multi-omics approaches can help define immune ecotypes in ccRCC and support more precise biomarker development.

Original Source(s)

Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics

  • by Zheng Zhang, Lijun He, Bin Chen, Huanle Zhang

  • July 15, 2026

Related Content

Consolidative versus salvage stereotactic ablative radiotherapy to the primary lung tumor in stage IV non–small cell lung cancer

EUS-guided transmural treatment of afferent loop syndrome: a systematic review and meta-analysis

Limited discriminative performance of endoscopic deep learning for Helicobacter pylori status assessment in gastric cancer patients: a retrospective study